Alemtuzumab and pyrexia Patient Reports February 13, 2012

Alemtuzumab Side Effects Report #5971708-1
Alemtuzumab side effect was reported by a Physician from GERMANY on Nov 10, 2008. Female patient, 56 years of age, was diagnosed with t-cell lymphoma and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: asthenia, blood potassium decreased, diarrhoea, fatigue, pyrexia. Alemtuzumab dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PEGFILGRASTIM, CARMUSTINE, ETOPOSIDE, CYTARABINE. Patient was hospitalized. Patient recovered.

Alemtuzumab Side Effects Report #6119038-1
Alemtuzumab side effect was reported by a Physician from GERMANY on Mar 10, 2009. Female patient, 56 years of age, was diagnosed with t-cell lymphoma and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: asthenia, blood potassium decreased, diarrhoea, fatigue, pyrexia. Alemtuzumab dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PEGFILGRASTIM, CARMUSTINE, ETOPOSIDE, CYTOSINE ARABINOSIDE. Patient was hospitalized. Patient recovered.

Alemtuzumab Side Effects Report #6119104-0
Alemtuzumab side effect was reported by a Physician from GERMANY on Mar 10, 2009. Female patient, 56 years of age, was diagnosed with t-cell lymphoma and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: asthenia, blood potassium decreased, diarrhoea, fatigue, pyrexia. Alemtuzumab dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PEGFILGRASTIM, CARMUSTINE, ETOPOSIDE, CYTARABINE. Patient was hospitalized. Patient recovered.

Alemtuzumab Side Effects Report #5732705-4
Alemtuzumab side effect was reported by a Physician from GERMANY on Apr 25, 2008. Female patient, 70 years of age, weighting 167.6 lb, was diagnosed with chronic lymphocytic leukaemia recurrent, antiviral prophylaxis, antibiotic prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: asthenia, hypertension, pyrexia. Alemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, VALTREX, COTRIM, PARACETAMOL, TAVEGIL. Patient recovered.


Alemtuzumab Side Effects Report #6085323-5
Alemtuzumab side effect was reported by a Physician from NETHERLANDS on Feb 12, 2009. Female patient, 48 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: abdominal pain , pyrexia. Alemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Alemtuzumab Side Effects Report #5808335-2
Alemtuzumab side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Mar 07, 2008. Female patient was diagnosed with bone marrow failure, prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hyperbilirubinaemia, infection , pyrexia, rash . Alemtuzumab dosage: TOTAL DAILY DOSE: 10 MG. During the same period patient was treated with CYCLOSPORINE, CIPROFLOXACIN, ACYCLOVIR, BACTRIM. Patient died.

Alemtuzumab Side Effects Report #5809549-8
Alemtuzumab side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Mar 07, 2008. Female patient was diagnosed with bone marrow failure, prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hyperbilirubinaemia, infection , pyrexia, rash . Alemtuzumab dosage: TOTAL DAILY DOSE: 10 MG. During the same period patient was treated with CYCLOSPORINE, CIPROFLOXACIN, ACYCLOVIR, BACTRIM. Patient died.